{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:59:10Z","timestamp":1780937950662,"version":"3.54.1"},"posted":{"date-parts":[[2025,10,15]]},"group-title":"In Review","reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,6,9]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background:<\/bold>\n                  Ending the HIV epidemic requires achieving HIV viral load (HVL) suppression for key populations including those with risky drinking. Gabapentin can decrease alcohol use and thus holds potential for improving medication adherence and HIV viral load suppression for individuals with HIV and risky drinking.\n                  <bold>Methods:<\/bold>\n                  To describe the protocol for arandomized, double-blinded, placebo-controlled trial, (GRAIL [Gabapentin to Reduce Alcohol and Improve viral Load suppression]), to test the efficacy of gabapentin versus placebo on achieving undetectable HIV viral load among people with HIV with risky drinking. We recruit and randomize 300 people with detectable HIV viral loads (&gt;= 200 copies\/ml) and risky drinking. Participants are randomized 1:1 to receive either gabapentin (1800 mg\/day target dose) or placebo for 3 months in a double blind design. Both arms receive a 5-minute evidence-based counseling session aimed at reducing alcohol use. The primary outcome is undetectable viral load (&lt;200 copies\/ml) at 3 months. Other secondary outcomes include undetectable viral load at 6 and 12 months, biomarker-confirmed recent alcohol consumption, antiretroviral therapy (ART) adherence, engagement in HIV care and pain severity. This study takes place in Mbarara, Uganda, as the country ranks among the top five for alcohol consumption globally and has 1.4 million people living with HIV.\n                  <bold>Discussion:<\/bold>\n                  GRAIL tests the efficacy of gabapentin, a medication to decrease alcohol use to achieve HIV viral load suppression. This trial may identify a treatment strategy to prevent the transmission of HIV and improve health outcomes among a high risk HIV population, specifically those with risky drinking.\n                  <bold>Trial registration:<\/bold>\n                  This trial has been registered at ClinicalTrials.gov (NCT05443555) on June 29, 2022. https:\/\/clinicaltrials.gov\/study\/NCT05443555?term=NCT05443555&amp;rank=1\n                <\/p>","DOI":"10.21203\/rs.3.rs-6856284\/v1","type":"posted-content","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:16:14Z","timestamp":1760544974000},"source":"Crossref","is-referenced-by-count":1,"title":["Gabapentin to achieve HIV viral load suppression in people with risky drinking in Mbarara, Uganda: study protocol for a randomized, double-blinded, placebo-controlled trial (GRAIL)"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8606-9209","authenticated-orcid":false,"given":"Ve","family":"Truong","sequence":"first","affiliation":[{"name":"Boston Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Kekibiina","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Muyindike","sequence":"additional","affiliation":[{"name":"Mbarara University of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Gnatienko","sequence":"additional","affiliation":[{"name":"Boston Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith I","family":"Tsui","sequence":"additional","affiliation":[{"name":"University of Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka I","family":"Emenyonu","sequence":"additional","affiliation":[{"name":"University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie M","family":"Cheng","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Hahn","sequence":"additional","affiliation":[{"name":"University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Allison","sequence":"additional","affiliation":[{"name":"Boston Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Bullard","sequence":"additional","affiliation":[{"name":"Boston University School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Lunze","sequence":"additional","affiliation":[{"name":"Boston Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H","family":"Samet","sequence":"additional","affiliation":[{"name":"Boston Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. HIV Country Intelligence. HIV Country Profiles 2022. https:\/\/cfs.hivci.org. Accessed 23 Sept 2023."},{"key":"ref2","unstructured":"UNAIDS. Fast-Track\u2014Ending the AIDS epidemic by 2030. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/201506_JC2743_Understanding_FastTrack_en.pdf. Accessed 30 Dec 2022."},{"key":"ref3","unstructured":"Uganda: New WHO Data Reveal Worryingly High Levels of Alcohol Use - Movendi International. https:\/\/movendi.ngo\/news\/2023\/05\/27\/uganda-new-who-data-reveal-worryingly-high-levels-of-alcohol-use. Accessed 1 Nov 2023."},{"key":"ref4","unstructured":"World Health Organization. Alcohol, total per capita (15+) consumption (in litres of pure alcohol). 2020. https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/total-(recorded-unrecorded)-alcohol-per-capita-(15-)-consumption. Accessed 1 Nov 2023."},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s10461-019-02716-0","article-title":"Alcohol use and antiretroviral therapy non-adherence among adults living with HIV\/AIDS in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"24","author":"Velloza J","year":"2020","unstructured":"Velloza J, Kemp CG, Aunon FM, Ramaiya MK, Creegan E, Simoni JM. Alcohol use and antiretroviral therapy non-adherence among adults living with HIV\/AIDS in Sub-Saharan Africa: a systematic review and meta-analysis. AIDS Behav. 2020;24(6):1727\u201342.","journal-title":"AIDS Behav"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAD.0000000000002427","article-title":"Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa","volume":"34","author":"Puryear SB","year":"2020","unstructured":"Puryear SB, Balzer LB, Ayieko J, KWARISIIMA D, Hahn JA, Charlebois ED, et al. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. AIDS. 2020;34(3):405\u201313.","journal-title":"AIDS"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/add.14655","article-title":"A Meta-analysis of the efficacy of gabapentin for treating alcohol use disorder","volume":"114","author":"Kranzler HR","year":"2019","unstructured":"Kranzler HR, Feinn R, Morris P, Hartwell EE. A Meta-analysis of the efficacy of gabapentin for treating alcohol use disorder. Addiction. 2019;114(9):1547\u201355.","journal-title":"Addiction"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason BJ","year":"2014","unstructured":"Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A. Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med. 2014;174(1):70\u20137.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"ref9","first-page":"19r02465","article-title":"Effectiveness of gabapentin in reducing cravings and withdrawal in alcohol use disorder: a meta-analytic review","volume":"21","author":"Ahmed S","year":"2019","unstructured":"Ahmed S, Stanciu CN, Kotapati PV, Ahmed R, Bhivandkar S, Khan AM, et al. Effectiveness of gabapentin in reducing cravings and withdrawal in alcohol use disorder: a meta-analytic review. Prim Care Companion CNS Disord. 2019;21(4):19r02465.","journal-title":"Prim Care Companion CNS Disord"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.46747\/cfp.6704269","article-title":"Gabapentin for alcohol use disorder","volume":"67","author":"Weresch J","year":"2021","unstructured":"Weresch J, Kirkwood J, Korownyk CS. Gabapentin for alcohol use disorder. Can Fam Physician. 2021;67(4):269.","journal-title":"Can Fam Physician"},{"issue":"6","key":"ref11","first-page":"CD007938","article-title":"Gabapentin for chronic neuropathic pain in adults","volume":"2017","author":"Wiffen PJ","year":"2017","unstructured":"Wiffen PJ, Derry S, Bell RF, Rice AS, T\u00f6lle TR, Phillips T, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;2017(6):CD007938.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","unstructured":"National Institute on Alcohol Abuse and Alcoholism. A pocket guide for alcohol screening and brief intervention. 2005. https:\/\/pubs.niaaa.nih.gov\/publications\/Practitioner\/pocketguide\/pocket_guide.htm. Accessed 1 Nov 2023."},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.3390\/ijms131114788","article-title":"Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis","volume":"13","author":"Viel G","year":"2012","unstructured":"Viel G, Boscolo-Berto R, Cecchetto G, Fais P, Nalesso A, Ferrara SD. Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis. Int J Mol Sci. 2012;13(11):14788\u2013812.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"e2225129","DOI":"10.1001\/jamanetworkopen.2022.25129","article-title":"Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial","volume":"5","author":"Tindle HA","year":"2022","unstructured":"Tindle HA, Freiberg MS, Cheng DM, Gnatienko N, Blokhina E, Yaroslavtseva T, et al. Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(8):e2225129.","journal-title":"JAMA Netw Open"},{"key":"ref15","author":"McLellan T","unstructured":"McLellan T, Cacciola J, Carise D, Coyne TH, Categories H. Addiction Severity Index Lite."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/09540120050042891","article-title":"Self-Reported Adherence to Antiretroviral Medications among Participants in HIV Clinical Trials: The AACTG Adherence Instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG)","volume":"12","author":"Chesney M","year":"2000","unstructured":"Chesney M, Ickovics JR, Chambers DB, Gifford A, Neidig J, Zwickl B, et al. Self-Reported Adherence to Antiretroviral Medications among Participants in HIV Clinical Trials: The AACTG Adherence Instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12:255\u201366.","journal-title":"AIDS Care"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7895\/ijadr.v5i2.222","article-title":"The Alcohol Use Disorders Identification Test (AUDIT): A review of graded severity algorithms and national adaptations","volume":"5","author":"Babor TF","year":"2016","unstructured":"Babor TF, Robaina K. The Alcohol Use Disorders Identification Test (AUDIT): A review of graded severity algorithms and national adaptations. Int J Alcohol Drug Res. 2016;5(2):17\u201324.","journal-title":"Int J Alcohol Drug Res"},{"key":"ref18","volume-title":"Alcohol Timeline Followback (TLFB) Users\u2019 Manual","author":"Sobell L","year":"1995","unstructured":"Sobell L, Sobell M. Alcohol Timeline Followback (TLFB) Users\u2019 Manual. Toronto, Canada: Alcohol Research Foundation; 1995."},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","article-title":"Psychometric properties of the Penn Alcohol Craving Scale","volume":"23","author":"Flannery BA","year":"1999","unstructured":"Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res. 1999;23(8):1289\u201395.","journal-title":"Alcohol Clin Exp Res"},{"key":"ref20","first-page":"355","volume-title":"Assessing drinkers\u2019 motivation for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES)","author":"Miller WR","year":"1997","unstructured":"Miller WR, Tonigan JS. Assessing drinkers\u2019 motivation for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Washington, DC, US: American Psychological Association; 1997. p. 355. Addictive behaviors: Readings on etiology, prevention, and treatment)."},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire","volume":"86","author":"Heatherton TF","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstr\u00f6m KO. The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire. Br J Addict. 1991;86(9):1119\u201327.","journal-title":"Br J Addict"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12888-016-1178-x","article-title":"Validation of the 10-item Centre for Epidemiological Studies Depression Scale (CES-D-10) in Zulu, Xhosa and Afrikaans populations in South Africa","volume":"17","author":"Baron EC","year":"2017","unstructured":"Baron EC, Davies T, Lund C. Validation of the 10-item Centre for Epidemiological Studies Depression Scale (CES-D-10) in Zulu, Xhosa and Afrikaans populations in South Africa. BMC Psychiatry. 2017;17:6.","journal-title":"BMC Psychiatry"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7","volume":"166","author":"Spitzer RL","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Arch Intern Med. 2006;166(10):1092.","journal-title":"Arch Intern Med"},{"issue":"0 1","key":"ref24","first-page":"E237","article-title":"Perceived alcohol stigma: factor structure and construct validation","volume":"37","author":"Glass JE","year":"2013","unstructured":"Glass JE, Kristjansson SD, Bucholz KK. Perceived alcohol stigma: factor structure and construct validation. Alcohol Clin Exp Res. 2013;37(0 1):E237\u201346.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jadohealth.2006.08.001","article-title":"Stigma Scale Revised: Reliability and Validity of a Brief Measure of Stigma For HIV\u2009+\u2009Youth","volume":"40","author":"Wright K","year":"2007","unstructured":"Wright K, Naar-King S, Lam P, Templin T, Frey M. Stigma Scale Revised: Reliability and Validity of a Brief Measure of Stigma For HIV\u2009+\u2009Youth. J Adolesc Health. 2007;40(1):96\u20138.","journal-title":"J Adolesc Health"},{"issue":"Suppl 1","key":"ref26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10461-021-03414-6","article-title":"HIV Stigma Among a National Probability Sample of Adults with Diagnosed HIV-United States, 2018\u20132019","volume":"26","author":"Beer L","year":"2022","unstructured":"Beer L, Tie Y, McCree DH, Demeke HB, Marcus R, Padilla M, et al. HIV Stigma Among a National Probability Sample of Adults with Diagnosed HIV-United States, 2018\u20132019. AIDS Behav. 2022;26(Suppl 1):39\u201350.","journal-title":"AIDS Behav"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/nur.10011","article-title":"Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale\u00b6","volume":"24","author":"Berger BE","year":"2001","unstructured":"Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale\u00b6. Res Nurs Health. 2001;24(6):518\u201329.","journal-title":"Res Nurs Health"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archinte.158.6.626","article-title":"Health-Related Quality of Life in Patients Served by the Department of Veterans Affairs: Results From the Veterans Health Study","volume":"158","author":"Kazis LE","year":"1998","unstructured":"Kazis LE, Miller DR, Clark J, Skinner K, Lee A, Rogers W, et al. Health-Related Quality of Life in Patients Served by the Department of Veterans Affairs: Results From the Veterans Health Study. Arch Intern Med. 1998;158(6):626\u201332.","journal-title":"Arch Intern Med"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jphys.2015.07.001","article-title":"The Brief Pain Inventory (BPI)","volume":"62","author":"Poquet N","year":"2016","unstructured":"Poquet N, Lin C. The Brief Pain Inventory (BPI). J Physiother. 2016;62(1):52.","journal-title":"J Physiother"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1023\/A:1005132430171","article-title":"Coping, conflictual social interactions, social support, and mood among HIV-infected persons. HCSUS Consortium","volume":"28","author":"Fleishman JA","year":"2000","unstructured":"Fleishman JA, Sherbourne CD, Crystal S, Collins RL, Marshall GN, Kelly M, et al. Coping, conflictual social interactions, social support, and mood among HIV-infected persons. HCSUS Consortium. Am J Community Psychol. 2000;28(4):421\u201353.","journal-title":"Am J Community Psychol"},{"key":"ref31","author":"Kapica M","unstructured":"Kapica M. The Veterans RAND 12 Item."},{"issue":"1\u20133","key":"ref32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.schres.2010.01.021","article-title":"Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients","volume":"118","author":"Vernon MK","year":"2010","unstructured":"Vernon MK, Revicki DA, Awad AG, Dirani R, Panish J, Canuso CM, et al. Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients. Schizophr Res. 2010;118(1\u20133):271\u20138.","journal-title":"Schizophr Res"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6856284\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6856284\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:10:10Z","timestamp":1780935010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6856284\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":32,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6856284\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13063-026-09813-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,10,15]]},"subtype":"preprint"}}